Item type |
琉球大学リポジトリ登録用アイテムタイプ(1) |
公開日 |
2023-07-18 |
タイトル |
|
|
タイトル |
Does cognitive behavioral therapy for anxiety disorders assist the discontinuation of benzodiazepines among patients with anxiety disorders? A systematic review and meta-analysis |
|
言語 |
en |
作成者 |
Takeshima, Masahiro
Otsubo, Tempei
Funada, Daisuke
Murakami, Maki
Usami, Takashi
Maeda, Yoshihiro
Yamamoto, Taisuke
Matsumoto, Toshihiko
Shimane, Takuya
Aoki, Yumi
Otowa, Takeshi
Tani, Masayuki
Yamanaka, Gaku
Sakai, Yojiro
Murao, Tomohiko
Inada, Ken
Yamada, Hiroki
Kikuchi, Toshiaki
Sasaki, Tsukasa
Watanabe, Norio
Mishima, Kazuo
Takaesu, Yoshikazu
|
アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
権利情報 |
|
|
言語 |
en |
|
権利情報 |
© 2021 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology |
権利情報 |
|
|
言語 |
en |
|
権利情報Resource |
https://creativecommons.org/licenses/by/4.0/ |
|
権利情報 |
This is an open access article under the terms of the Creative Commons Attribution License |
主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
anxiety disorder |
主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
anxiolytics |
主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
benzodiazepines |
主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
cognitive behavioral therapy |
主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
meta-analysis |
内容記述 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
Long-term use of benzodiazepines (BZD) is not recommended for the treatment of anxiety disorders. Cognitive behavioral therapy (CBT) is an effective treatment option for discontinuation of BZD in patients with anxiety disorders. This systematic review and meta-analysis sought to clarify whether CBT is effective for discontinuing BZD anxiolytics in patients with anxiety disorders. This study was preregistered with PROSPERO (registration number: CRD42019125263). A literature search of major electronic databases was conducted in December 2018. Three randomized controlled trials were included in this review, and meta-analyses were performed. The proportion of discontinuing BZD anxiolytics was significantly higher in the CBT plus gradual tapering group than in the gradual tapering alone group, both in the short term (3 months after allocation; number needed to treat: 3.2, 95% confidence interval [CI]: 2.1 to 7.1; risk ratio: 1.96, 95%CI: 1.29 to 2.98, P = 0.002, three studies) and long term (6 to 12 months after allocation; number needed to treat: 2.8, 95%CI: 1.9 to 5.3; risk ratio: 2.16, 95%CI: 1.41 to 3.32, P = 0.0004, three studies). CBT may be effective for discontinuing BZD anxiolytics, both in the short term and in the long term after the allocation. Further studies with larger sample sizes are necessary to draw definitive conclusions regarding the efficacy and safety of CBT for discontinuing BZD anxiolytics in patients with anxiety disorders. |
|
言語 |
en |
出版者 |
|
|
出版者 |
© 2021 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology |
|
言語 |
en |
言語 |
|
|
言語 |
eng |
資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
関連情報 |
|
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
https://doi.org/10.1111/pcn.13195 |
収録物識別子 |
|
|
収録物識別子タイプ |
EISSN |
|
収録物識別子 |
1440-1819 |
収録物名 |
|
|
収録物名 |
Psychiatry and Clinical Neurosciences |
|
言語 |
en |
書誌情報 |
巻 75,
号 4,
p. 119-127,
発行日 2021-01-15
|